Login / Signup

Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer.

Zekai ShuBaiqiang DongLei ShiWei ShenQingqing HangJin WangYuan-Yuan Chen
Published in: Journal of cancer research and clinical oncology (2020)
SBRT appears to be effective and safe for NSCLC patients aged ≥ 75 years, with no adverse impact on nutritional status and self-care ability.
Keyphrases
  • early stage
  • end stage renal disease
  • radiation therapy
  • ejection fraction
  • small cell lung cancer
  • newly diagnosed
  • chronic kidney disease
  • emergency department
  • tyrosine kinase
  • epidermal growth factor receptor